| Palm Point Behavioral Health | |
|
2355 Truman Scarborough Way Titusville FL 32796-1310 | |
| (817) 271-8720 | |
| Not Available |
| Full Name | Palm Point Behavioral Health |
|---|---|
| Speciality | Psychiatric Hospital |
| Location | 2355 Truman Scarborough Way, Titusville, Florida |
| Authorized Official Name and Position | Steve Filton (VICE PRESIDENT) |
| Authorized Official Contact | 6107683300 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Palm Point Behavioral Health 2355 Truman Scarborough Way Titusville FL 32796-1310 Ph: () - | Palm Point Behavioral Health 2355 Truman Scarborough Way Titusville FL 32796-1310 Ph: (817) 271-8720 |
| NPI Number | 1235635533 |
|---|---|
| Provider Enumeration Date | 04/04/2018 |
| Last Update Date | 12/14/2020 |
| Certification Date | 12/14/2020 |
| Medicare PECOS PAC ID | 0345504528 |
|---|---|
| Medicare Enrollment ID | O20181210001503 |
News Archive
Scientists from The Institute of Cancer Research have developed a technique which will markedly help in predicting the behaviour of prostate cancer.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the conclusion of the first Phase II trial testing its unique new hemostat Fibrocaps(TM). Promising preliminary data from the European multicenter, open-label trial show compelling safety and efficacy (time to hemostasis) profiles for Fibrocaps, and good performance of the delivery device.
Former Kaiser Permanente CEO George Halvorson and Blue Shield of California CEO Paul Markovich share their perspectives on where Obamacare is headed and how the nation can curb health care spending.
When lots of energy hits an atom, it can knock off electrons, making the atom extremely chemically reactive and initiating further destruction. That's why radiation is so dangerous. It's also why high-resolution imaging techniques that use energetic electron beams and X-rays can alter, even obliterate, the samples they explore. For example, monitoring battery dynamics using electron microscopy can introduce artifacts that interfere with electrochemical processes.
Christie Medical Holdings, Inc. today announced the market launch of the company's newest product, VeinViewer Flex. With the addition of this fifth-generation VeinViewer, following the recent launch of VeinViewer VisionXTND, Christie now provides a full portfolio of three product tiers that addresses the needs of every major health care market segment.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235635533 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | (* (Not Available)) | Secondary |
| 283Q00000X | Psychiatric Hospital | (* (Not Available)) | Primary |
| Provider Name | Donald Baracskay |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1760564207 PECOS PAC ID: 3072406891 Enrollment ID: I20090822000068 |
News Archive
Scientists from The Institute of Cancer Research have developed a technique which will markedly help in predicting the behaviour of prostate cancer.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the conclusion of the first Phase II trial testing its unique new hemostat Fibrocaps(TM). Promising preliminary data from the European multicenter, open-label trial show compelling safety and efficacy (time to hemostasis) profiles for Fibrocaps, and good performance of the delivery device.
Former Kaiser Permanente CEO George Halvorson and Blue Shield of California CEO Paul Markovich share their perspectives on where Obamacare is headed and how the nation can curb health care spending.
When lots of energy hits an atom, it can knock off electrons, making the atom extremely chemically reactive and initiating further destruction. That's why radiation is so dangerous. It's also why high-resolution imaging techniques that use energetic electron beams and X-rays can alter, even obliterate, the samples they explore. For example, monitoring battery dynamics using electron microscopy can introduce artifacts that interfere with electrochemical processes.
Christie Medical Holdings, Inc. today announced the market launch of the company's newest product, VeinViewer Flex. With the addition of this fifth-generation VeinViewer, following the recent launch of VeinViewer VisionXTND, Christie now provides a full portfolio of three product tiers that addresses the needs of every major health care market segment.
› Verified 8 days ago
| Provider Name | Joseph Llinas |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1013962158 PECOS PAC ID: 5597902189 Enrollment ID: I20130801000902 |
News Archive
Scientists from The Institute of Cancer Research have developed a technique which will markedly help in predicting the behaviour of prostate cancer.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the conclusion of the first Phase II trial testing its unique new hemostat Fibrocaps(TM). Promising preliminary data from the European multicenter, open-label trial show compelling safety and efficacy (time to hemostasis) profiles for Fibrocaps, and good performance of the delivery device.
Former Kaiser Permanente CEO George Halvorson and Blue Shield of California CEO Paul Markovich share their perspectives on where Obamacare is headed and how the nation can curb health care spending.
When lots of energy hits an atom, it can knock off electrons, making the atom extremely chemically reactive and initiating further destruction. That's why radiation is so dangerous. It's also why high-resolution imaging techniques that use energetic electron beams and X-rays can alter, even obliterate, the samples they explore. For example, monitoring battery dynamics using electron microscopy can introduce artifacts that interfere with electrochemical processes.
Christie Medical Holdings, Inc. today announced the market launch of the company's newest product, VeinViewer Flex. With the addition of this fifth-generation VeinViewer, following the recent launch of VeinViewer VisionXTND, Christie now provides a full portfolio of three product tiers that addresses the needs of every major health care market segment.
› Verified 8 days ago
| Provider Name | Robert Nastasi |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1467608521 PECOS PAC ID: 6507008364 Enrollment ID: I20140915001658 |
News Archive
Scientists from The Institute of Cancer Research have developed a technique which will markedly help in predicting the behaviour of prostate cancer.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the conclusion of the first Phase II trial testing its unique new hemostat Fibrocaps(TM). Promising preliminary data from the European multicenter, open-label trial show compelling safety and efficacy (time to hemostasis) profiles for Fibrocaps, and good performance of the delivery device.
Former Kaiser Permanente CEO George Halvorson and Blue Shield of California CEO Paul Markovich share their perspectives on where Obamacare is headed and how the nation can curb health care spending.
When lots of energy hits an atom, it can knock off electrons, making the atom extremely chemically reactive and initiating further destruction. That's why radiation is so dangerous. It's also why high-resolution imaging techniques that use energetic electron beams and X-rays can alter, even obliterate, the samples they explore. For example, monitoring battery dynamics using electron microscopy can introduce artifacts that interfere with electrochemical processes.
Christie Medical Holdings, Inc. today announced the market launch of the company's newest product, VeinViewer Flex. With the addition of this fifth-generation VeinViewer, following the recent launch of VeinViewer VisionXTND, Christie now provides a full portfolio of three product tiers that addresses the needs of every major health care market segment.
› Verified 8 days ago
| Provider Name | Trisa Marie Danz |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1598109241 PECOS PAC ID: 3971847419 Enrollment ID: I20181210002903 |
News Archive
Scientists from The Institute of Cancer Research have developed a technique which will markedly help in predicting the behaviour of prostate cancer.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the conclusion of the first Phase II trial testing its unique new hemostat Fibrocaps(TM). Promising preliminary data from the European multicenter, open-label trial show compelling safety and efficacy (time to hemostasis) profiles for Fibrocaps, and good performance of the delivery device.
Former Kaiser Permanente CEO George Halvorson and Blue Shield of California CEO Paul Markovich share their perspectives on where Obamacare is headed and how the nation can curb health care spending.
When lots of energy hits an atom, it can knock off electrons, making the atom extremely chemically reactive and initiating further destruction. That's why radiation is so dangerous. It's also why high-resolution imaging techniques that use energetic electron beams and X-rays can alter, even obliterate, the samples they explore. For example, monitoring battery dynamics using electron microscopy can introduce artifacts that interfere with electrochemical processes.
Christie Medical Holdings, Inc. today announced the market launch of the company's newest product, VeinViewer Flex. With the addition of this fifth-generation VeinViewer, following the recent launch of VeinViewer VisionXTND, Christie now provides a full portfolio of three product tiers that addresses the needs of every major health care market segment.
› Verified 8 days ago
| Provider Name | Mayra Alexandra Abelleira Martinez |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1669819983 PECOS PAC ID: 4486907748 Enrollment ID: I20181210003044 |
News Archive
Scientists from The Institute of Cancer Research have developed a technique which will markedly help in predicting the behaviour of prostate cancer.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the conclusion of the first Phase II trial testing its unique new hemostat Fibrocaps(TM). Promising preliminary data from the European multicenter, open-label trial show compelling safety and efficacy (time to hemostasis) profiles for Fibrocaps, and good performance of the delivery device.
Former Kaiser Permanente CEO George Halvorson and Blue Shield of California CEO Paul Markovich share their perspectives on where Obamacare is headed and how the nation can curb health care spending.
When lots of energy hits an atom, it can knock off electrons, making the atom extremely chemically reactive and initiating further destruction. That's why radiation is so dangerous. It's also why high-resolution imaging techniques that use energetic electron beams and X-rays can alter, even obliterate, the samples they explore. For example, monitoring battery dynamics using electron microscopy can introduce artifacts that interfere with electrochemical processes.
Christie Medical Holdings, Inc. today announced the market launch of the company's newest product, VeinViewer Flex. With the addition of this fifth-generation VeinViewer, following the recent launch of VeinViewer VisionXTND, Christie now provides a full portfolio of three product tiers that addresses the needs of every major health care market segment.
› Verified 8 days ago
| Provider Name | Sajid Hafeez |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1225083389 PECOS PAC ID: 9739183732 Enrollment ID: I20190204001964 |
News Archive
Scientists from The Institute of Cancer Research have developed a technique which will markedly help in predicting the behaviour of prostate cancer.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the conclusion of the first Phase II trial testing its unique new hemostat Fibrocaps(TM). Promising preliminary data from the European multicenter, open-label trial show compelling safety and efficacy (time to hemostasis) profiles for Fibrocaps, and good performance of the delivery device.
Former Kaiser Permanente CEO George Halvorson and Blue Shield of California CEO Paul Markovich share their perspectives on where Obamacare is headed and how the nation can curb health care spending.
When lots of energy hits an atom, it can knock off electrons, making the atom extremely chemically reactive and initiating further destruction. That's why radiation is so dangerous. It's also why high-resolution imaging techniques that use energetic electron beams and X-rays can alter, even obliterate, the samples they explore. For example, monitoring battery dynamics using electron microscopy can introduce artifacts that interfere with electrochemical processes.
Christie Medical Holdings, Inc. today announced the market launch of the company's newest product, VeinViewer Flex. With the addition of this fifth-generation VeinViewer, following the recent launch of VeinViewer VisionXTND, Christie now provides a full portfolio of three product tiers that addresses the needs of every major health care market segment.
› Verified 8 days ago
| Provider Name | Naren T Vellanki |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1336594563 PECOS PAC ID: 3173879178 Enrollment ID: I20210506001250 |
News Archive
Scientists from The Institute of Cancer Research have developed a technique which will markedly help in predicting the behaviour of prostate cancer.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the conclusion of the first Phase II trial testing its unique new hemostat Fibrocaps(TM). Promising preliminary data from the European multicenter, open-label trial show compelling safety and efficacy (time to hemostasis) profiles for Fibrocaps, and good performance of the delivery device.
Former Kaiser Permanente CEO George Halvorson and Blue Shield of California CEO Paul Markovich share their perspectives on where Obamacare is headed and how the nation can curb health care spending.
When lots of energy hits an atom, it can knock off electrons, making the atom extremely chemically reactive and initiating further destruction. That's why radiation is so dangerous. It's also why high-resolution imaging techniques that use energetic electron beams and X-rays can alter, even obliterate, the samples they explore. For example, monitoring battery dynamics using electron microscopy can introduce artifacts that interfere with electrochemical processes.
Christie Medical Holdings, Inc. today announced the market launch of the company's newest product, VeinViewer Flex. With the addition of this fifth-generation VeinViewer, following the recent launch of VeinViewer VisionXTND, Christie now provides a full portfolio of three product tiers that addresses the needs of every major health care market segment.
› Verified 8 days ago
| Provider Name | Usama Ahmad Rafique |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1629463369 PECOS PAC ID: 3274871223 Enrollment ID: I20211215001661 |
News Archive
Scientists from The Institute of Cancer Research have developed a technique which will markedly help in predicting the behaviour of prostate cancer.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the conclusion of the first Phase II trial testing its unique new hemostat Fibrocaps(TM). Promising preliminary data from the European multicenter, open-label trial show compelling safety and efficacy (time to hemostasis) profiles for Fibrocaps, and good performance of the delivery device.
Former Kaiser Permanente CEO George Halvorson and Blue Shield of California CEO Paul Markovich share their perspectives on where Obamacare is headed and how the nation can curb health care spending.
When lots of energy hits an atom, it can knock off electrons, making the atom extremely chemically reactive and initiating further destruction. That's why radiation is so dangerous. It's also why high-resolution imaging techniques that use energetic electron beams and X-rays can alter, even obliterate, the samples they explore. For example, monitoring battery dynamics using electron microscopy can introduce artifacts that interfere with electrochemical processes.
Christie Medical Holdings, Inc. today announced the market launch of the company's newest product, VeinViewer Flex. With the addition of this fifth-generation VeinViewer, following the recent launch of VeinViewer VisionXTND, Christie now provides a full portfolio of three product tiers that addresses the needs of every major health care market segment.
› Verified 8 days ago
News Archive
Scientists from The Institute of Cancer Research have developed a technique which will markedly help in predicting the behaviour of prostate cancer.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the conclusion of the first Phase II trial testing its unique new hemostat Fibrocaps(TM). Promising preliminary data from the European multicenter, open-label trial show compelling safety and efficacy (time to hemostasis) profiles for Fibrocaps, and good performance of the delivery device.
Former Kaiser Permanente CEO George Halvorson and Blue Shield of California CEO Paul Markovich share their perspectives on where Obamacare is headed and how the nation can curb health care spending.
When lots of energy hits an atom, it can knock off electrons, making the atom extremely chemically reactive and initiating further destruction. That's why radiation is so dangerous. It's also why high-resolution imaging techniques that use energetic electron beams and X-rays can alter, even obliterate, the samples they explore. For example, monitoring battery dynamics using electron microscopy can introduce artifacts that interfere with electrochemical processes.
Christie Medical Holdings, Inc. today announced the market launch of the company's newest product, VeinViewer Flex. With the addition of this fifth-generation VeinViewer, following the recent launch of VeinViewer VisionXTND, Christie now provides a full portfolio of three product tiers that addresses the needs of every major health care market segment.
› Verified 8 days ago
Thomas F. Guidera, Ph.d, P.a. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1777 Garden Street, Titusville, FL 32796 Phone: 321-268-5682 Fax: 321-268-5683 | |
Family Builders Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1010 Norwood Ave, Titusville, FL 32796 Phone: 321-432-8295 Fax: 321-267-8491 | |
Alpha Medical Consulting Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 123 S Park Ave, Titusville, FL 32796 Phone: 321-298-5531 | |
Ref Nurse Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 605 S Palm Ave, Titusville, FL 32796 Phone: 321-289-2818 | |
Dj Sustainable Progress Consulting Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2503 S Washington Ave Ste 1264, Titusville, FL 32780 Phone: 407-915-1877 Fax: 877-915-7798 | |
Space Coast Health Centers Inc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 951 N Washington Ave Ste 100, Titusville, FL 32796 Phone: 386-852-9565 | |
Latino Leadership, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4403 S Hopkins Ave, Titusville, FL 32780 Phone: 407-895-0801 Fax: 407-895-0803 |